OTP
gene geneOn this page
Summary
OTP (orthopedia homeobox, HGNC:8518) is a protein-coding gene on chromosome 5q14.1, encoding Homeobox protein orthopedia (Q5XKR4). Probably involved in the differentiation of hypothalamic neuroendocrine cells.
This gene encodes a member of the homeodomain (HD) family. HD family proteins are helix-turn-helix transcription factors that play key roles in the specification of cell fates. This protein may function during brain development.
Source: NCBI Gene 23440 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 38 total
- MANE Select transcript:
NM_032109
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:8518 |
| Approved symbol | OTP |
| Name | orthopedia homeobox |
| Location | 5q14.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000171540 |
| Ensembl biotype | protein_coding |
| OMIM | 604529 |
| Entrez | 23440 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000306422, ENST00000515716
RefSeq mRNA: 1 — MANE Select: NM_032109
NM_032109
CCDS: CCDS4039
Canonical transcript exons
ENST00000306422 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001163048 | 77636821 | 77637230 |
| ENSE00001169222 | 77628712 | 77630794 |
| ENSE00001169228 | 77638513 | 77638713 |
Expression profiles
Bgee: expression breadth broad, 27 present calls, max score 72.42.
Top tissues by expression
235 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| pancreatic ductal cell | CL:0002079 | 72.42 | silver quality |
| tibialis anterior | UBERON:0001385 | 71.58 | silver quality |
| hypothalamus | UBERON:0001898 | 70.42 | gold quality |
| ileal mucosa | UBERON:0000331 | 64.93 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 64.02 | gold quality |
| deltoid | UBERON:0001476 | 58.98 | silver quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 54.33 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 53.39 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 52.71 | gold quality |
| seminal vesicle | UBERON:0000998 | 50.56 | gold quality |
| myocardium | UBERON:0002349 | 50.25 | gold quality |
| lower lobe of lung | UBERON:0008949 | 49.49 | silver quality |
| buccal mucosa cell | CL:0002336 | 49.33 | gold quality |
| medulla oblongata | UBERON:0001896 | 49.31 | silver quality |
| quadriceps femoris | UBERON:0001377 | 48.44 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 47.99 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 47.03 | gold quality |
| vastus lateralis | UBERON:0001379 | 45.74 | gold quality |
| colonic epithelium | UBERON:0000397 | 44.91 | gold quality |
| upper leg skin | UBERON:0004262 | 44.77 | silver quality |
| biceps brachii | UBERON:0001507 | 44.76 | gold quality |
| amniotic fluid | UBERON:0000173 | 44.72 | gold quality |
| ventricular zone | UBERON:0003053 | 44.68 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 43.55 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-8894 | yes | 1572.01 |
| E-ANND-3 | no | 1.47 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
2 targets.
| Target | Regulation |
|---|---|
| SLC6A3 | Activation |
| TH | Activation |
Upstream regulators (CollecTRI, top): TBXT
miRNA regulators (miRDB)
65 targeting OTP, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-LET-7C-3P | 99.95 | 73.42 | 2862 |
| HSA-MIR-218-5P | 99.93 | 72.22 | 2103 |
| HSA-MIR-9902 | 99.89 | 69.15 | 2250 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-4447 | 99.85 | 67.81 | 2900 |
| HSA-MIR-765 | 99.84 | 68.24 | 2442 |
| HSA-MIR-4698 | 99.84 | 71.41 | 4303 |
| HSA-MIR-6756-5P | 99.82 | 67.97 | 2466 |
| HSA-MIR-6875-3P | 99.82 | 70.26 | 2983 |
| HSA-MIR-577 | 99.78 | 69.13 | 2479 |
| HSA-MIR-11181-3P | 99.75 | 66.38 | 2205 |
| HSA-MIR-6885-3P | 99.75 | 70.36 | 3187 |
| HSA-MIR-6745 | 99.74 | 65.33 | 1321 |
| HSA-MIR-4719 | 99.73 | 72.10 | 3329 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-379-3P | 99.69 | 69.60 | 1524 |
| HSA-MIR-411-3P | 99.69 | 69.63 | 1524 |
| HSA-MIR-6766-5P | 99.68 | 67.70 | 2325 |
Literature-anchored findings (GeneRIF, showing 6)
- we successfully identified a novel gene OTP frequently methylated in breast cancer by genome-wide screening. Our results suggest that the OTP gene may play a crucial role in breast carcinogenesis. (PMID:22366991)
- Data indicate that low mRNA expression levels of CD44 and orthopedia homeobox (OTP) and high levels of RET, were strongly associated with a low 20-year survival of carcinoid patients. (PMID:23444222)
- Our results suggest that OTP may serve as a useful diagnostic marker for lung carcinoid tumors. (PMID:26927888)
- We tested the functional consequences of the novel human OTP mutations and Q83K as well as the mouse R108W mutant; all affect residues that are highly conserved across species. On a single site response element, wild-type OTP was found to act as a repressor; both R108W and Q153R abolished this repression (PMID:29107289)
- Orthopedia protein (OTP) is specific for lung carcinoids because well-differentiated nonlung neuroendocrine tumors are negative for OTP. OTP preferentially stains typical carcinoids over atypical carcinoids (PMID:29316326)
- Half of the pulmonary TC tumors expressed OTP. (PMID:30284410)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | otpa | ENSDARG00000014201 |
| danio_rerio | otpb | ENSDARG00000058379 |
| mus_musculus | Otp | ENSMUSG00000021685 |
| rattus_norvegicus | Otp | ENSRNOG00000010560 |
Paralogs (50): ARX (ENSG00000004848), PAX6 (ENSG00000007372), PAX7 (ENSG00000009709), ALX4 (ENSG00000052850), GSC2 (ENSG00000063515), PITX1 (ENSG00000069011), PAX2 (ENSG00000075891), RHOXF1 (ENSG00000101883), CRX (ENSG00000105392), EVX1 (ENSG00000106038), PAX4 (ENSG00000106331), NOBOX (ENSG00000106410), PITX3 (ENSG00000107859), PHOX2B (ENSG00000109132), OTX1 (ENSG00000115507), PRRX1 (ENSG00000116132), VSX2 (ENSG00000119614), ESX1 (ENSG00000123576), PAX8 (ENSG00000125618), PAX1 (ENSG00000125813), RHOXF2 (ENSG00000131721), GSC (ENSG00000133937), RAX (ENSG00000134438), PAX3 (ENSG00000135903), ALX3 (ENSG00000156150), HESX1 (ENSG00000163666), PITX2 (ENSG00000164093), UNCX (ENSG00000164853), PHOX2A (ENSG00000165462), OTX2 (ENSG00000165588), DRGX (ENSG00000165606), PRRX2 (ENSG00000167157), SHOX2 (ENSG00000168779), RAX2 (ENSG00000173976), EVX2 (ENSG00000174279), PROP1 (ENSG00000175325), ISX (ENSG00000175329), ALX1 (ENSG00000180318), MIXL1 (ENSG00000185155), SHOX (ENSG00000185960)
Protein
Protein identifiers
Homeobox protein orthopedia — Q5XKR4 (reviewed: Q5XKR4)
All UniProt accessions (1): Q5XKR4
UniProt curated annotations — full annotation on UniProt →
Function. Probably involved in the differentiation of hypothalamic neuroendocrine cells.
Subcellular location. Nucleus.
Similarity. Belongs to the paired homeobox family. Bicoid subfamily.
RefSeq proteins (1): NP_115485* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000047 | HTH_motif | Conserved_site |
| IPR001356 | HD | Domain |
| IPR003654 | OAR_dom | Domain |
| IPR009057 | Homeodomain-like_sf | Homologous_superfamily |
| IPR017970 | Homeobox_CS | Conserved_site |
| IPR051895 | OTP_Homeobox | Family |
Pfam: PF00046, PF03826
UniProt features (6 total): compositionally biased region 2, chain 1, DNA-binding region 1, region of interest 1, short sequence motif 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5XKR4-F1 | 62.73 | 0.19 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 190 (showing top):
YAATNRNNNYNATT_UNKNOWN, BENPORATH_ES_WITH_H3K27ME3, HNF3ALPHA_Q6, NKX25_02, GCANCTGNY_MYOD_Q6, GOBP_PITUITARY_GLAND_DEVELOPMENT, GOBP_NEUROGENESIS, RACCACAR_AML_Q6, GOBP_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT, CHX10_01, GOBP_POSITIVE_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT, GOBP_POSITIVE_REGULATION_OF_NEUROBLAST_PROLIFERATION, GCGCTTT_MIR518B_MIR518C_MIR518D, GOBP_FOREBRAIN_DEVELOPMENT, SHEPARD_BMYB_MORPHOLINO_DN
GO Biological Process (12): negative regulation of transcription by RNA polymerase II (GO:0000122), positive regulation of neuroblast proliferation (GO:0002052), neuroblast proliferation (GO:0007405), forebrain neuron differentiation (GO:0021879), hypothalamus cell differentiation (GO:0021979), neurohypophysis development (GO:0021985), neuron differentiation (GO:0030182), neuroendocrine cell differentiation (GO:0061101), dopaminergic neuron differentiation (GO:0071542), regulation of DNA-templated transcription (GO:0006355), nervous system development (GO:0007399), cell differentiation (GO:0030154)
GO Molecular Function (5): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227), DNA binding (GO:0003677), protein binding (GO:0005515)
GO Cellular Component (5): chromatin (GO:0000785), fibrillar center (GO:0001650), nucleoplasm (GO:0005654), nuclear body (GO:0016604), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| regulation of transcription by RNA polymerase II | 2 |
| generation of neurons | 2 |
| cell differentiation | 2 |
| neuron differentiation | 2 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| transcription by RNA polymerase II | 1 |
| negative regulation of DNA-templated transcription | 1 |
| neuroblast proliferation | 1 |
| positive regulation of neurogenesis | 1 |
| regulation of neuroblast proliferation | 1 |
| positive regulation of neural precursor cell proliferation | 1 |
| neural precursor cell proliferation | 1 |
| forebrain generation of neurons | 1 |
| central nervous system neuron differentiation | 1 |
| hypothalamus development | 1 |
| pituitary gland development | 1 |
| gland development | 1 |
| neuroepithelial cell differentiation | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| system development | 1 |
| cellular developmental process | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| negative regulation of transcription by RNA polymerase II | 1 |
| DNA-binding transcription factor activity, RNA polymerase II-specific | 1 |
| DNA-binding transcription repressor activity | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| chromosome | 1 |
| nucleolus | 1 |
| nuclear lumen | 1 |
| nucleoplasm | 1 |
| intracellular membraneless organelle | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
838 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OTP | SIM1 | P81133 | 859 |
| OTP | POU3F2 | P20265 | 774 |
| OTP | OXT | P01178 | 742 |
| OTP | ACTR1B | P42025 | 665 |
| OTP | ACTR1A | P42024 | 656 |
| OTP | SIX3 | O95343 | 625 |
| OTP | ARNT2 | Q9HBZ2 | 619 |
| OTP | SIM2 | Q14190 | 568 |
| OTP | TRH | P20396 | 562 |
| OTP | PAX2 | Q02962 | 544 |
| OTP | FOXB1 | Q99853 | 511 |
| OTP | ONECUT1 | Q9UBC0 | 478 |
| OTP | CRH | P06850 | 463 |
| OTP | NHLH2 | Q02577 | 446 |
| OTP | FEZF2 | Q8TBJ5 | 438 |
| OTP | TBR1 | Q16650 | 438 |
IntAct
26 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| EOMES | OTP | psi-mi:“MI:0915”(physical association) | 0.560 |
| OTP | CPNE7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| OTP | BEX1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCL21 | OTP | psi-mi:“MI:0915”(physical association) | 0.560 |
| OTP | TPGS2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PDE6D | OTP | psi-mi:“MI:0915”(physical association) | 0.560 |
| CDK6 | OTP | psi-mi:“MI:0915”(physical association) | 0.560 |
| OTP | SLC12A7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| OTP | FLAD1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| OTP | EOMES | psi-mi:“MI:0915”(physical association) | 0.000 |
| CPNE7 | OTP | psi-mi:“MI:0915”(physical association) | 0.000 |
| BEX1 | OTP | psi-mi:“MI:0915”(physical association) | 0.000 |
| CDK6 | OTP | psi-mi:“MI:0915”(physical association) | 0.000 |
| CCL21 | OTP | psi-mi:“MI:0915”(physical association) | 0.000 |
| TPGS2 | OTP | psi-mi:“MI:0915”(physical association) | 0.000 |
| PDE6D | OTP | psi-mi:“MI:0915”(physical association) | 0.000 |
| SLC12A7 | OTP | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (10): OTP (Two-hybrid), OTP (Two-hybrid), OTP (Two-hybrid), OTP (Two-hybrid), OTP (Two-hybrid), OTP (Two-hybrid), OTP (Two-hybrid), CPNE7 (Two-hybrid), FLAD1 (Affinity Capture-MS), OTP (Negative Genetic)
ESM2 similar proteins: A3RK74, A3RK75, A4L7N3, B3LYS5, B3P0K6, B4HF64, B4MB78, E1BPQ1, F1R8Z9, G3V7R4, O09113, O43524, O93385, P23512, P32183, P35582, P35584, P41161, P55317, P56673, P70314, P78337, P97474, Q00939, Q05826, Q12778, Q28EM1, Q32NP8, Q3BJS1, Q5XKR4, Q60987, Q66JJ0, Q68EZ2, Q68F77, Q6EUW1, Q6EUW2, Q810W5, Q8K3Q3, Q8R5I7, Q969V6
Diamond homologs: A1A546, A1YEV8, A1YG25, A2T711, A6NJT0, A6NNA5, A6YP92, G5EC89, G5EDS1, L8E946, O08934, O09113, O14813, O15266, O18381, O35085, O35137, O35602, O35690, O35750, O42115, O42201, O42250, O42356, O42357, O42358, O42477, O42567, O60902, O70137, O73917, O95076, O97039, P0DMV5, P23759, P23760, P24610, P26367, P26630, P29506
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
38 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 37 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
622 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 5:77630801:C:CT | acceptor_gain | 1.0000 |
| 5:77630802:G:T | acceptor_gain | 1.0000 |
| 5:77630805:C:CT | acceptor_gain | 1.0000 |
| 5:77630806:G:T | acceptor_gain | 1.0000 |
| 5:77630790:CAGAC:C | acceptor_gain | 0.9900 |
| 5:77630791:AGAC:A | acceptor_gain | 0.9900 |
| 5:77630792:GAC:G | acceptor_gain | 0.9900 |
| 5:77630793:AC:A | acceptor_gain | 0.9900 |
| 5:77630794:CC:C | acceptor_gain | 0.9900 |
| 5:77630795:C:CC | acceptor_gain | 0.9900 |
| 5:77630795:CTG:C | acceptor_loss | 0.9900 |
| 5:77630796:T:A | acceptor_loss | 0.9900 |
| 5:77630810:C:CT | acceptor_gain | 0.9900 |
| 5:77630811:G:T | acceptor_gain | 0.9900 |
| 5:77636815:TCGTA:T | donor_loss | 0.9800 |
| 5:77636816:CGTAC:C | donor_loss | 0.9800 |
| 5:77636817:GTACC:G | donor_loss | 0.9800 |
| 5:77636818:TACC:T | donor_loss | 0.9800 |
| 5:77636819:ACCT:A | donor_loss | 0.9800 |
| 5:77636820:C:T | donor_loss | 0.9800 |
| 5:77637920:T:A | donor_gain | 0.9700 |
| 5:77630795:C:T | acceptor_gain | 0.9600 |
| 5:77630793:ACC:A | acceptor_gain | 0.9400 |
| 5:77630794:CCT:C | acceptor_gain | 0.9400 |
| 5:77630795:CT:C | acceptor_gain | 0.9400 |
| 5:77630796:T:G | acceptor_gain | 0.9400 |
| 5:77630791:AGACC:A | acceptor_gain | 0.9300 |
| 5:77630792:GACC:G | acceptor_gain | 0.9300 |
| 5:77637942:T:A | donor_gain | 0.9300 |
| 5:77636669:C:CT | acceptor_gain | 0.9200 |
AlphaMissense
2094 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 5:77630289:T:G | H318P | 1.000 |
| 5:77630299:C:G | A315P | 1.000 |
| 5:77630304:C:G | R313P | 1.000 |
| 5:77630307:C:G | R312P | 1.000 |
| 5:77630308:G:T | R312S | 1.000 |
| 5:77630310:A:G | L311P | 1.000 |
| 5:77630310:A:T | L311H | 1.000 |
| 5:77630319:A:C | I308S | 1.000 |
| 5:77630319:A:G | I308T | 1.000 |
| 5:77630319:A:T | I308N | 1.000 |
| 5:77630321:G:C | S307R | 1.000 |
| 5:77630321:G:T | S307R | 1.000 |
| 5:77630322:C:A | S307I | 1.000 |
| 5:77630323:T:G | S307R | 1.000 |
| 5:77630759:C:A | K161N | 1.000 |
| 5:77630759:C:G | K161N | 1.000 |
| 5:77630761:T:C | K161E | 1.000 |
| 5:77630762:C:A | K160N | 1.000 |
| 5:77630762:C:G | K160N | 1.000 |
| 5:77630763:T:A | K160M | 1.000 |
| 5:77630764:T:C | K160E | 1.000 |
| 5:77630765:C:A | W159C | 1.000 |
| 5:77630765:C:G | W159C | 1.000 |
| 5:77630766:C:G | W159S | 1.000 |
| 5:77630767:A:G | W159R | 1.000 |
| 5:77630767:A:T | W159R | 1.000 |
| 5:77630768:C:A | K158N | 1.000 |
| 5:77630768:C:G | K158N | 1.000 |
| 5:77630769:T:A | K158M | 1.000 |
| 5:77630770:T:C | K158E | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000572659 (5:77628648 T>A,C), RS1000922471 (5:77628254 G>A,C,T), RS1000997008 (5:77633915 A>G), RS1001049638 (5:77639707 C>A), RS1001050227 (5:77629319 C>T), RS1001109921 (5:77634195 A>G), RS1001503960 (5:77629641 G>A), RS1001660491 (5:77631338 C>G,T), RS1001773519 (5:77631551 C>A,T), RS1002002542 (5:77632532 G>A), RS1002118567 (5:77632884 A>G), RS1002212757 (5:77639282 C>A,G,T), RS1002423611 (5:77638665 G>A), RS1002524223 (5:77630312 G>A,C), RS1002665047 (5:77629711 C>T)
Disease associations
OMIM: gene MIM:604529 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST90000047_102 | Age at first sexual intercourse | 3.000000e-08 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009749 | age at first sexual intercourse measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| methylmercuric chloride | decreases expression | 1 |
| arsenite | increases methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Demecolcine | increases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Hydrogen Peroxide | affects cotreatment, decreases expression, increases expression | 1 |
| Methyl Methanesulfonate | decreases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Theophylline | increases expression, affects cotreatment, decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Vincristine | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Asbestos, Crocidolite | decreases methylation | 1 |
| Asbestos, Amosite | decreases methylation | 1 |
| Cadmium Chloride | increases expression, increases abundance | 1 |
Cellosaurus cell lines
3 cell lines: 3 embryonic stem cell
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_A5A8 | SEES3-1V human OTP, clone1 | Embryonic stem cell | Male |
| CVCL_A5A9 | SEES3-1V human OTP, clone2 | Embryonic stem cell | Male |
| CVCL_A5B0 | SEES3-1V human OTP, clone3 | Embryonic stem cell | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.